ITRASPORAX 100 CAP features Itraconazole 100 mg, a highly effective antifungal medication from the triazole class. It works by inhibiting fungal cytochrome P450 enzymes involved in ergosterol synthesis, a vital component of fungal cell membranes. This disruption results in fungal cell death and clearance of infection.

Itraconazole is known for its broad antifungal spectrum, targeting a wide range of yeasts and molds, including species resistant to other azoles like fluconazole. It is especially effective due to its lipophilic nature, which allows it to accumulate in skin, nails, and mucosal tissues, offering long-term protection against relapses.

Indications and Therapeutic Applications

ITRASPORAX 100 CAP is used for the treatment of:

Dermatophytosis (ringworm infections of the skin, groin, feet)

Pityriasis versicolor

Onychomycosis (fungal nail infections)

Oral and esophageal candidiasis

Systemic fungal infections (aspergillosis, histoplasmosis, blastomycosis)

Vaginal candidiasis

Sporotrichosis and cryptococcosis

Fungal keratitis and resistant fungal infections

Key Features and Benefits

Broad-spectrum antifungal effective against both yeasts and molds

High bioavailability and tissue penetration

Effective in resistant or recurrent infections

Suitable for long-term therapy due to sustained tissue levels

Oral administration with better patient compliance

Manufactured to international pharmaceutical export standards

Dosage and Administration

Standard adult dosage:

100–200 mg once or twice daily depending on infection severity

For dermatophyte infections:

100 mg once daily for 15 days (skin)

200 mg once daily for 7 days (nail infections – pulse therapy)

For systemic infections:

200 mg to 400 mg/day based on physician’s discretion

Best taken after a full meal for maximum absorption

Note: Dosage must be tailored by a healthcare provider based on indication and patient profile.